Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/1999
03/30/1999US5888820 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
03/30/1999US5888817 For breast and prostate cancer cells
03/30/1999US5888816 Cell cultures of and cell culturing method for nontransformed pancreatic, thyroid, and parathyroid cells
03/30/1999US5888815 Cell cultivation method and medium
03/30/1999US5888814 Recombinant host cells encoding TNF proteins
03/30/1999US5888813 Monoclonal antibodies against human pancreatic islet cells
03/30/1999US5888809 Hamster EF-1α transcriptional regulatory DNA
03/30/1999US5888807 Devices for maintaining and growing human stem and/or hematopoietics cells
03/30/1999US5888801 Bacillus thuringiensis
03/30/1999US5888790 Modified Acyl-ACP desaturase
03/30/1999US5888789 Malting monocot plant seeds
03/30/1999US5888772 Amino acid sequences of mutants with higher biological activity; for treatment of anemia and induction of erythropoiesis
03/30/1999US5888771 Gene products as targets for the development of antibiotics.
03/30/1999US5888767 Method of using a conditionally replicating viral vector to express a gene
03/30/1999US5888753 Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
03/30/1999US5888749 Hybridomas; immunoassay
03/30/1999US5888735 Cancer drug screen based on cell cycle uncoupling
03/30/1999US5888732 Recombinational cloning using engineered recombination sites
03/30/1999US5888720 To replace or supplement the endogenous tissue.
03/30/1999US5888705 Pancreatic cells to treat type 1 diabetes mellitus. the invention relates to the use of a human cytokine, hepatocyte growth factor/scatter factor (?hgf/sf?).
03/30/1999US5888517 Protein D-an IgD-binding protein of Haemophilus influenzae
03/30/1999US5888513 Porcine reproductive and respiratory syndrome virus proteins, and amino acid sequences encoding them; produced in a baculovirus expression system using insect cell cultures as host
03/30/1999US5888508 Monoclonal antibodies against leukocyte adhesion receptor β-chain methods of producing these antibodies and use therefore
03/30/1999US5888506 A detergent free polypeptide in the form of crystal structure or lyophilized or conjugated with polyoxyethylene glycol and contains less than 1 ng endotoxin per mg protein
03/30/1999US5888499 Containing myeloblasts
03/30/1999US5888498 Cellular and animal models for diseases associated with mitochondrial defects
03/30/1999US5888497 Encapsulated cells
03/30/1999US5888248 Dermal-epidermal in vitro test system
03/30/1999CA2166707C New stromal cell lines from human bone marrow and their use
03/30/1999CA2039843C Ultra-lightweight, open-pore foamed cellulose materials with large surface areas, having ion-exchangeable functional groups introduced therein
03/25/1999WO1999014353A2 Intrabody-mediated control of immune reactions
03/25/1999WO1999014350A1 Rank1, an ankyrin-repeat containing peptide from rice associated with disease resistance
03/25/1999WO1999014343A1 Dna encoding a ras carboxyl-terminal processing protein
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014334A1 Peptides derived from the attachment (g) protein of respiratory syncytial virus
03/25/1999WO1999014331A2 Cyclin-dependent kinase inhibitors and uses thereof
03/25/1999WO1999014330A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014326A1 Mage-3 peptides presented by hla class ii molecules
03/25/1999WO1999014322A2 Allelic variant of human stat3
03/25/1999WO1999014320A1 CHROMOSOMAL MUTAGENESIS IN $i(PICHIA METHANOLICA)
03/25/1999WO1999014316A2 Synthetic hybrid plant promoter
03/25/1999WO1999014314A1 Regulation of gene expression in plants
03/25/1999WO1999014310A1 Rna export element and methods of use
03/25/1999WO1999014243A1 Immunointeractive molecules and uses therefor
03/25/1999WO1999014237A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections
03/25/1999WO1999014236A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
03/25/1999WO1999014235A1 Persephin and related growth factors
03/25/1999WO1999013904A1 T-cell vaccination for the treatment of multiple sclerosis
03/25/1999WO1999013896A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999WO1999013886A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
03/25/1999WO1999013818A2 Membrane virus host range mutations and their uses as vaccine substrates
03/25/1999WO1999013726A1 Neuronal cells and an immunosuppressant and anti-inflammatory factor
03/25/1999WO1999013719A1 Chemical modification of dna using peptide nucleic acid conjugates
03/25/1999WO1999000494A3 Cell activation process and reagents therefor
03/25/1999WO1999000151A3 Cell culture products
03/25/1999WO1998058068A3 A method for plant protection against insects or nematodes
03/25/1999WO1998055508A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
03/25/1999WO1998054225A3 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
03/25/1999WO1998050530A9 Enzymatic nucleic acids: synthesis, selection and use
03/25/1999WO1998049268A9 Natural killer cell lines and methods of use
03/25/1999WO1998048001A9 Methods for differentiating neural stem cells
03/25/1999CA2382506A1 Novel polypeptides and nucleic acids encoding pro293 which are useful for treating disorders of the pancreas
03/25/1999CA2382495A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2382409A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2304373A1 T-cell vaccination for the treatment of multiple sclerosis
03/25/1999CA2304312A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
03/25/1999CA2304309A1 Dna encoding a ras carboxyl-terminal processing protein
03/25/1999CA2304257A1 Synthetic hybrid plant promoter
03/25/1999CA2304208A1 Intrabody-mediated control of immune reactions
03/25/1999CA2304125A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999CA2303908A1 Chemical modification of dna using peptide nucleic acid conjugates
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303759A1 Cyclin-dependent kinase inhibitors and uses thereof
03/25/1999CA2303397A1 Macrophage derived chemokine (mdc) as an anti-viral agent for the treatment and prevention of lentivirus infections
03/25/1999CA2303227A1 Human prl-1 phosphatase
03/25/1999CA2303225A1 Dna30942 polypeptide, a tnfr homolog
03/25/1999CA2296045A1 Persephin and related growth factors
03/24/1999EP0903409A2 Aminopeptidase (AmpS)
03/24/1999EP0903408A2 Tat-derived transport polypeptide
03/24/1999EP0903150A1 Regulation of immunoglobulin production by interleukin-9
03/24/1999EP0902839A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells
03/24/1999EP0902838A1 Methods for producing and transforming cassave protoplasts
03/24/1999EP0902836A1 Asymmetric hammerhead ribozymes
03/24/1999EP0902791A1 Extracellular/epidermal growth factor hcaba58x
03/24/1999EP0756003B1 Method of culturing animal cells
03/24/1999EP0705346B1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof
03/24/1999EP0556320B1 Monoclonal antibodies to hepatitis c virus and method for using the same
03/24/1999CN1212017A Hybrid proteins which form heterodimers
03/24/1999CN1212016A Recombinant ribonuclease proteins
03/24/1999CN1212009A Ungulate embryonic stem-like cells, method of making and using cells to produce transgenic ungulates
03/24/1999CN1211989A Composition and method for delivery of nucleic acids
03/24/1999CN1211918A TNF－α转变酶 TNF-α converting enzyme
03/24/1999CA2216686A1 Allelic variants of the phospholipase c-gamma1 gene associated with bipolar disorder
03/23/1999US5886166 Viricides; htlv; a trna primer for reverse transcription of a murine leukemia virus retroviral transfer vector having sequences in the primer binding site replaced to prevent strong base pairing with naturally occuring trna
03/23/1999US5886152 Humanized antibody produced by transplantation of complementarity-determining region of a mouse monoclonal antibody b-b10 specific to a human interleukin-2 receptor into a human antody; genetic engineering
03/23/1999US5886145 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
03/23/1999US5885971 Gene therapy by secretory gland expression
03/23/1999US5885963 Administering to said pests, or the environment of said pests, a pesticidally effective amount of a bacillus thuringiensis delta-endotoxin from the bacillus thuringiensis isolate ps123d1
1 ... 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 ... 1827